1 / 7

JSB Market Research: Xalkori (Non-Small Cell Lung Cancer)

Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy.

michaeldellk22
Download Presentation

JSB Market Research: Xalkori (Non-Small Cell Lung Cancer)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Xalkori (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022 To buy this Report Visit http://www.jsbmarketresearch.com

  2. Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment landscape into smaller niche patient populations. Over the forecast period, this trend will continue with the launch of multiple new drugs in several new drug classes to address the high unmet need among NSCLC patients, and provide new treatment options for previously underserved populations. Launch of premium-priced drug candidates combined with increasing incident cases of the disease will be major drivers of growth in the major markets.

  3. Reason To Buy This Report: • Understand and capitalize by identifying products that are most likely to ensure a robust return • Stay ahead of the competition by understanding the changing competitive landscape for NSCLC • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential • Make more informed business decisions from insightful and in-depth analysis of Xalkoriperformance • Obtain sales forecast for Xalkori from 2012-2022 in top nine countries (the US, France, Germany, Italy, Spain, the UK, Japan, India and China) To know more about this report click here – http://www.jsbmarketresearch.com/healthcare-medical/r-Xalkori-Non-Small-Cell-Lung-Cancer-Forecast-and-Market-Analysis-to-2022-114975

  4. Xalkori (Non-Small Cell Lung Cancer) Disease Overview Disease Management Competitive Assessment Xalkori (crizotinib)

  5. Related Market Research Report • Orion Corporation (ORNBV) - Financial and Strategic SWOT Analysis Review • BioLineRx, Ltd. (BLRX) - Financial and Strategic SWOT Analysis Review • SupernusPharmaceuticals, Inc. (SUPN) - Financial and Strategic SWOT Analysis Review • Targacept, Inc. (TRGT) - Financial and Strategic SWOT Analysis Review

  6. About JSB Market Research • Jsbmarketresearch.com is an online repository of an extensive collection of market research reports available online. This online portal contains high-quality reports with well-researched and high-quality content on a wide range of industries. These market research reports help us give a detailed insight into new opportunities in the industry, prevailing market trends, competitor analysis and future prospects. • JSB’s reports are developed by the domain experts and publishers under a closely observed surveillance of industry specialists. Therefore, the researched data is well researched, well- organized and matching up to the best standards in the industry. Also JSB’s database consists of detailed insights of the leading players in the global market, products and trends.

  7. Contact Us Support & General Inquiries Mail :support@jsbmarketresearch.com1-800-986-4312 Billing Support Mail :billing@jsbmarketresearch.com+91 22 412 366 50 Websitehttp://www.jsbmarketresearch.com

More Related